According to FutureWise analysis the market for acute migraine treatment in 2023 was US$ 2.52 billion, and is expected to reach US$ 3.76 billion by 2031 at a CAGR of 5.10%. Migraine is a prevalent neurological condition characterized by recurrent and often debilitating headache attacks. These attacks can be accompanied by various symptoms, including heightened sensitivity to light, sound,...